Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 5;14(1):18113.
doi: 10.1038/s41598-024-69294-7.

Controlled labelling of tracer antibodies for time-resolved fluorescence-based immunoassays

Affiliations

Controlled labelling of tracer antibodies for time-resolved fluorescence-based immunoassays

Anastasiia Kushnarova-Vakal et al. Sci Rep. .

Abstract

Tracer antibodies, which are labelled with fluorescent or other type of reporter molecules, are widely employed in diagnostic immunoassays. Time-resolved fluorescence immunoassay (TRFIA), recognized as one of the most sensitive immunoassay techniques, utilizes tracers labelled with lanthanide ion (Ln) chelates. The conventional approach for conjugating isothiocyanate (ITC) Ln-chelates to antibodies involves random chemical targeting of the primary amino group of Lys residues, requiring typically overnight exposure to an elevated pH of 9-9.3 and leading to heterogeneity. Moreover, efforts to enhance the sensitivity of the assays by introducing a higher number of Ln-chelates per tracer antibody are associated with an elevated risk of targeting critical amino acid residues in the binding site, compromising the binding properties of the antibody. Herein, we report a method to precisely label recombinant antibodies with a defined number of Ln-chelates in a well-controlled manner by employing the SpyTag/SpyCatcher protein ligation technology. We demonstrate the functionality of the method with a full-length recombinant antibody (IgG) as well as an antibody fragment by producing site-specifically labelled antibodies for TRFIA for cardiac troponin I (cTnI) detection with a significant improvement in assay sensitivity compared to that with conventionally labelled tracer antibodies. Overall, our data clearly illustrates the benefits of the site-specific labelling strategy for generating high-performing tracer antibodies for TRF immunoassays.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Production of 11N11 scFv-SpyCatcher003 antibody in E. coli. (A) Schematic representation of the recombinant pHBSC3 expression vector. SC3, SpyCatcher003; variable light chain (VL) and variable heavy chain (VH) connected via a short linker form a single-chain variable fragment (scFv). (B) SDS-PAGE analysis of SEC-purified 11N11 scFv-SpyCatcher003 antibody. The input corresponds to the Ni-NTA elution sample. M, molecular weight markers.
Figure 2
Figure 2
Transient expression of IgG-SpyCatcher003 antibodies in mammalian cells. (A) Schematic representation of the recombinant pcDNA 3.4 expression vector. LC, light chain; HC, heavy chain; SC3, SpyCatcher003. (B) SDS-PAGE analysis of protein A purified IgG and IgG-SpyCatcher003 antibodies. M, molecular weight markers. A full image of the SDS-PAGE gel is provided in Supplementary Information.
Figure 3
Figure 3
Labelling and purification of SpyTag003-polyK peptide. (A) Schematic representation of the reaction between SpyTag003-polyK peptide and Eu(III)-N1-ITC chelate. (B) HPLC chromatogram of the Eu-labelled SpyTag003-polyK peptide.
Figure 4
Figure 4
Coupling of 11N11 scFv-SpyCatcher003 antibody with SpyTag003 and SpyTag003-polyK peptides. (A) SDS-PAGE analysis of 11N11 scFv-SpyCatcher003 antibody coupled with SpyTag003 and SpyTag003-polyK peptides. (B) SEC profiles of 11N11 scFv-SpyCatcher003 before (black) and after (grey) coupling with SpyTag003 peptide. (C) Differential scanning fluorimetry (DSF) curve of the 11N11 scFv-SpyCatcher003 before (black) and after (grey) coupling with SpyTag003 peptide.
Figure 5
Figure 5
Analysis of 11N11 IgG-SpyCatcher003 antibody complexation with the SpyTag003 and SpyTag003-polyK peptides. (A) SDS-PAGE analysis of 11N11 IgG-SpyCatcher003 antibody (lane 2) and as coupled with SpyTag003 peptide (lane 3) and SpyTag003-polyK peptide (lane 4). A full image of the SDS-PAGE gel is provided in Supplementary Information. (B) Isoelectric focusing (IEF) of 11N11 IgG-SpyCatcher003 antibody (lane 1) and as complex with SpyTag003 peptide (lane 2) and with SpyTag003-polyK peptide (lane 3). A full image of the IEF gel is provided in Supplementary Information. (C) DSF curve of the 11N11 IgG-SpyCatcher003 before (black) and after (grey) coupling with SpyTag003 peptide.
Figure 6
Figure 6
Performance evaluation for site-specifically labelled 11N11 scFv-SpyCatcher003/SpyTag003-polyK antibody in TRFIA. (A) Detection of the cTnI with site-specifically labelled 11N11 scFv-SpyCatcher003/SpyTag003-polyK antibody (black; 7.9 Eu-chelates/scFv) and non-specifically labelled scFv-SpyCatcher003/SpyTag003 antibodies (grey; 2.3 Eu-chelates/scFv and 7.2 Eu-chelates/scFv). (B) Detection of the cTnI with site-specifically labelled 11N11 IgG-SpyCatcher003/SpyTag003-polyK antibody (black; 17.8 Eu-chelates/IgG) and non-specifically labelled IgG-SpyCatcher003/SpyTag003 antibodies (grey; 2.8 Eu-chelates/IgG, 8.7 Eu-chelates/IgG and 25.7 Eu-chelates/IgG). Data represents mean ± SD (n = 3).

Similar articles

Cited by

References

    1. Ducancel, F. & Muller, B. H. Molecular engineering of antibodies for therapeutic and diagnostic purposes. MAbs4, 445–457 (2012). 10.4161/mabs.20776 - DOI - PMC - PubMed
    1. Welch, N. G., Scoble, J. A., Muir, B. W. & Pigram, P. J. Orientation and characterization of immobilized antibodies for improved immunoassays. Biointerphases 12, 02D301 (2017). 10.1116/1.4978435 - DOI - PubMed
    1. Brockmann, E.-C., Vehniäinen, M. & Pettersson, K. Use of high-capacity surface with oriented recombinant antibody fragments in a 5-min immunoassay for thyroid-stimulating hormone. Anal. Biochem.396, 242–249 (2009). 10.1016/j.ab.2009.10.002 - DOI - PubMed
    1. Hyytiä, H., Järvenpää, M.-L., Ristiniemi, N., Lövgren, T. & Pettersson, K. A comparison of capture antibody fragments in cardiac troponin I immunoassay. Clin. Biochem.46, 963–968 (2013). 10.1016/j.clinbiochem.2013.01.012 - DOI - PubMed
    1. Diamandis, E. P. Immunoassays with time-resolved fluorescence spectroscopy: Principles and applications. Clin. Biochem.21, 139–150 (1988). 10.1016/S0009-9120(88)80104-8 - DOI - PubMed

LinkOut - more resources